Loading...
OTCM
VRSEF
Market cap88kUSD
Jul 17, Last price  
0.00USD
1D
0.00%
1Q
-60.34%
IPO
-87.43%
Name

Verisante Technology Inc

Chart & Performance

D1W1MN
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
-55.71%
Revenues
0k
030,45911,4092,2490775,300218,816139,00926,4000000
Net income
-91k
L
-885,118-861,762-1,484,602-3,551,003-3,510,756-4,896,112-3,233,406-2,389,571-1,641,585-43,963-192,2521,201,589-90,525
CFO
-111k
-855,856-734,480-932,458-1,916,408-3,027,507-3,428,797-1,388,479-720,888-338,443000-110,731

Profile

Verisante Technology Inc. does not have significant operations. Previously, it was involved in the design and manufacture of innovative cancer diagnostic devices. The company was formerly known as T-Ray Science Inc. and changed its name to Verisante Technology Inc. in January 2011. The company was incorporated in 2006 and is based in Vancouver, Canada.
IPO date
Dec 09, 2009
Employees
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFY
2023‑122022‑122021‑122020‑122016‑122015‑12
Income
Revenues
Cost of revenue
128
288
Unusual Expense (Income)
NOPBT
(128)
(288)
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
(128)
(288)
Net income
(91)
-107.53%
1,202
-725.01%
Dividends
Dividend yield
Proceeds from repurchase of equity
99
BB yield
-55.28%
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
22
67
Net debt
(30)
(86)
Cash flow
Cash from operating activities
(111)
CAPEX
Cash from investing activities
Cash from financing activities
55
129
FCF
(128)
(288)
Balance
Cash
30
86
Long term investments
Excess cash
30
86
Stockholders' equity
(5,023)
(5,016)
Invested Capital
5,033
5,078
ROIC
ROCE
EV
Common stock shares outstanding
34,073
16,510
Price
0.01
 
Market cap
178
 
EV
93
EBITDA
(128)
(288)
EV/EBITDA
Interest
Interest/NOPBT